But even if money were not an issue, Hill says, there are a number of other factors that could lead patients to decide not to take GLP-1s long-term (see below)
The clinical consequences could range from local inflammation or rash through to serious health issues, such as systemic hypersensitivity, including anaphylaxis, or antibody formation
Evaluation of the effect of intravenous l-carnitine on quality of life in chronic hemodialysis patients
The Precision Peptide Genetic Test identifies genetic variants in GLP1R signaling, GIPR sensitivity, and metabolic pathways that influence how your body responds to GLP-1 therapyincluding gastrointestinal tolerance patterns
So who should consider trying these medications
People with a personal or family history of medullary thyroid cancer, or those with multiple endocrine neoplasia syndrome type 2, should not use GLP-1 agonists at all and thus cannot combine them with fasting